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abstract
 
The cystic ﬁbrosis transmembrane conductance regulator (CFTR) is an ion channel that conducts
Cl
 
 
 
 current. We explored the CFTR pore by studying voltage-dependent blockade of the channel by two organic
anions: glibenclamide and isethionate. To simplify the kinetic analysis, a CFTR mutant, K1250A-CFTR, was used
because this mutant channel, once opened, can remain open for minutes. Dose–response relationships of both
blockers follow a simple Michaelis-Menten function with 
 
K
 
d
 
 values that differ by three orders of magnitude. Glib-
enclamide blocks CFTR from the intracellular side of the membrane with slow kinetics. Both the on and off rates
of glibenclamide block are voltage dependent. Removing external Cl
 
 
 
 increases afﬁnity of glibenclamide due to a
decrease of the off rate and an increase of the on rate, suggesting the presence of a Cl
 
 
 
 binding site external to
the glibenclamide binding site. Isethionate blocks the channel from the cytoplasmic side with fast kinetics, but has
no measurable effect when applied extracellularly. Increasing the internal Cl
 
 
 
 concentration reduces isethionate
block without affecting its voltage dependence, suggesting that Cl
 
 
 
 and isethionate compete for a binding site in
the pore. The voltage dependence and external Cl
 
 
 
 concentration dependence of isethionate block are nearly
identical to those of glibenclamide block, suggesting that these two blockers may bind to a common binding site,
an idea further supported by kinetic studies of blocking with glibenclamide/isethionate mixtures. By comparing
the physical and chemical natures of these two blockers, we propose that CFTR channel has an asymmetric pore
with a wide internal entrance and a deeply embedded blocker binding site where local charges as well as hydro-
phobic components determine the afﬁnity of the blockers.
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INTRODUCTION
 
Cystic ﬁbrosis transmembrane conductance regulator
(CFTR)* is an ion channel that conducts Cl
 
 
 
 ions (for
review see Sheppard and Welsh, 1999). Malfunction of
CFTR, due to mutations of the gene coding for CFTR,
results in cystic ﬁbrosis (Riordan et al., 1989). It is sug-
gested, from hydropathy studies, that CFTR consists of
two membrane-spanning domains, each of which con-
tains six transmembrane segments that are thought to
form the anion-selective pore. In addition to these two
membrane-spanning domains, there are two nucle-
otide-binding domains (NBD1 and NBD2) that pre-
sumably carry out the ATP hydrolysis reaction that
gates the channel, and a regulatory domain (R do-
main), phosphorylation of which regulates channel ac-
tivity (for review see Gadsby et al., 1995).
Despite numerous physiological and biophysical stud-
ies of CFTR functions, the structure of CFTR remains
undeﬁned due to a lack of crystal structure. However,
previous investigations using mutagenesis suggest that
the sixth transmembrane segment (TM6) may play an
important role in forming the pore (Tabcharani et al.,
1993; Akabas et al., 1994; Mansoura et al., 1998). Other
transmembrane segments, such as TM5 (Mansoura et
al., 1998) and TM12 (McCarty et al., 1993; McDonough
et al., 1994) may also contribute to the pore formation.
Since large organic anions (e.g., DIDS, DNDS, glu-
tamate, and gluconate) can only block the channel
when applied internally, it is proposed that the CFTR
pore is asymmetric with a relatively large internal vesti-
bule to accommodate those sizable blockers (Linsdell
and Hanrahan, 1996a,b; Linsdell et al., 1997). How-
ever, a symmetric pore model has been successfully
used to explain the selectivity mechanism among lyo-
tropic anions (Smith et al., 1999).
Several lines of evidence suggest multi-ion occupancy
of the CFTR pore. First, the anomalous mole fraction
effect between Cl
 
 
 
 and thiocyanate (SCN
 
 
 
), an indica-
tion of the existence of multi-ion binding sites, is ob-
served in wild-type CFTR (wt-CFTR). Since this effect is
abolished when the positive charge of Arg 347 (a resi-
due in TM6) is neutralized, it is thought that Arg 347
forms one of the anion binding sites inside the pore
(Tabcharani et al., 1993). Second, inhibition of the
CFTR channel by internally applied blockers is affected
by changing extracellular [Cl
 
 
 
] (Linsdell et al., 1997;
Sheppard and Robinson, 1997; Zhou et al., 2001b).
Since the off rate of the blocker is increased by increas-
 
ing extracellular [Cl
 
 
 
], this trans-ion effect can be
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explained by an electrostatic repulsion between the
blocker and the Cl
 
 
 
 ion simultaneously present in the
pore (e.g., Zhou et al., 2001b). However, it is also possi-
ble that external Cl
 
 
 
 and internally applied blocker
may compete for a common binding site (e.g., Shep-
pard and Robinson, 1997). This latter scenario would
predict that the on rate of the blocker is decreased by
increasing extracellular [Cl
 
 
 
]. Thus, to distinguish
these two mechanisms, it is essential to investigate how
external [Cl
 
 
 
] affects the association and dissociation
rates of the blocker with single-channel kinetic analysis.
Third, models with two or three binding sites have
been used successfully to describe gluconate and SCN
 
 
 
block of the CFTR channel (Linsdell et al., 1997). Re-
cently, a model with three binding sites is used to ex-
plain the role of Arg 334, a charged residue in TM6, in
conduction properties (Smith et al., 2001). However,
the multi-ion pore notion has been challenged by some
other reports. First, Cotton and Welsh (1999) conclude
that instead of forming an anion binding site directly,
Arg 347 may form a salt bridge with Asp 924 to stabilize
the channel architecture. Second, the anomalous mole
fraction effect described above is not observed in some
studies (Mansoura et al., 1998). In addition, a higher
single-channel conductance with SCN
 
 
 
 as the charge
carrier, observed in earlier experiments demonstrating
the anomalous mole fraction effect (Tabcharani et al.,
1993), is recently challenged (Linsdell, 2001). Third, a
single-ion pore model is shown to adequately explain
the anion selectivity of CFTR (Smith et al., 1999).
The goal of the current study is to probe the CFTR
channel with organic anion blockers to gain some in-
sight into the structural properties of the anion-con-
ducting pore. High afﬁnity blockers have been proven
to be invaluable tools in elucidating the pore structure
of ion channels. The most successful examples are the
well-known potassium channel blockers: TEA and its
derivatives (e.g., Armstrong, 1971; Miller, 1982; Choi et
al., 1993). Importantly, early biophysical work using
blockers to probe the properties of the ion binding
sites in the potassium channel pore is supported by re-
cent x-ray crystallographic studies of the KcsA potas-
sium channel (Doyle et al., 1998; Jiang and MacKin-
non, 2000; Zhou et al., 2001a). In this study, two or-
ganic anion blockers, glibenclamide and isethionate,
were used to probe the CFTR pore. Glibenclamide, the
most potent CFTR blocker found so far, is an anion
with large hydrophobic components (Schultz et al.,
1996; Sheppard and Robinson, 1997; Gupta and Lins-
dell, 2002). Here, mechanisms underlying the voltage-
dependent blockade by glibenclamide were studied in
detail using single-channel and whole-cell recordings.
On the other hand, isethionate is an anion that has
been used widely as a Cl
 
 
 
 substitute. Our results indi-
cate that isethionate effectively blocks CFTR and is
more potent than some of the known hydrophilic an-
ion blockers, such as gluconate and glutamate (Lins-
dell and Hanrahan, 1996b; Linsdell et al., 1997). It
blocks the channel from the cytoplasmic side of the
membrane with a voltage dependence that is nearly
identical to that of glibenclamide. In addition, re-
moving external Cl
 
 
 
 has virtually identical effects on
isethionate and glibenclamide blockage. Furthermore,
results obtained from experiments using mixtures of
glibenclamide and isethionate are consistent with a
model that two blockers compete for a common bind-
ing site. Structural implications of the CFTR pore
based on the comparison of physical and chemical na-
tures of glibenclamide and isethionate are discussed.
 
MATERIALS AND METHODS
 
Cell Preparation
 
NIH3T3 cells stably expressing K1250A-CFTR channels (Zelt-
wanger et al., 1999) were maintained at 37
 
 
 
C and 5% CO
 
2
 
 in Dul-
becco’s Modiﬁed Eagle’s Medium (DMEM) supplemented with
10% fetal bovine serum. Cells were passed twice a week in 25-cm
 
2
 
cell culture ﬂasks. 2–5 d before patch-clamp recordings, cells
were plated on small, sterile glass coverslips in 35-mm tissue cul-
ture dishes.
 
Single-channel Patch-clamp Recordings
 
Recording pipette electrodes were prepared with a two-stage ver-
tical puller (Narishige) and were then ﬁre polished using a
homemade microforge to yield a pipette resistance of 3–6 M
 
 
 
when ﬁlled with the standard pipette solution. Right before the
recording, a glass coverslip with cells grown on was placed into a
continuously perfused chamber on the stage of an inverted mi-
croscope (Olympus). The standard pipette (external) solution
(154 mM [Cl
 
 
 
]o) contained (in mM): 140 NMDG-Cl, 2 MgCl
 
2
 
, 5
CaCl
 
2
 
, and 10 Hepes (pH 7.4 with NMDG). In some experi-
ments, a pipette solution (0 Cl
 
 
 
 pipette solution) that contained
(in mM) 154 NMDG-aspartate, 2 MgSO
 
4
 
, and 10 HEPES (pH 7.4
with NMDG) was used to remove Cl
 
 
 
 in the external solution.
For these experiments, recording pipettes were ﬁrst ﬁlled with
the 0 Cl
 
 
 
 pipette solution and a 6 mM Cl
 
 
 
 pipette solution was
added onto the top portion of the pipette solution. The 6 mM
Cl
 
 
 
 pipette solution contained (in mM): 148 aspartate, 2 MgCl
 
2
 
,
1 CaCl
 
2
 
, and 10 HEPES (pH 7.4 with NMDG). Cells were per-
fused with a bath solution containing (in mM): 145 NaCl, 5 KCl,
2 MgCl
 
2
 
, 1 CaCl
 
2
 
, 5 glucose, 5 Hepes, and 20 sucrose (pH 7.4
with NaOH). After the establishment of an inside-out conﬁgura-
tion, the patch was perfused with a standard internal perfusion
solution (154 mM [Cl
 
 
 
]i) containing (in mM): 150 NMDG-Cl, 2
MgCl
 
2
 
, 10 EGTA, and 8 Tris (pH 7.4 with NMDG). For Cl
 
 
 
 com-
petition experiments, an internal perfusion solution containing
(in mM): 296 NMDG-Cl, 2 MgCl
 
2
 
, 10 EGTA, and 8 Tris (pH 7.4
with NMDG) was used.
Single-channel currents were recorded at room temperature
(
 
 
 
22
 
 
 
C) using an EPC9 patch-clamp ampliﬁer (Heka Elec-
tronic). Current traces were ﬁltered at 100 Hz with a built-in
4-pole Bessel ﬁlter and stored on videotapes. Stationary current
recordings were played back without further ﬁltering, digitized at
500 Hz, and stored on the hard disk. To quantify fast blockade by
isethionate, currents in response to 1 s voltage ramp ranging
from 
 
 
 
120 to 120 mV were recorded, ﬁltered at 100 Hz with a
built-in 4-pole Bessel ﬁlter, and digitized online at 2 kHz. 
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Whole-cell Patch-clamp Recordings
 
Whole-cell recordings were made using an EPC9 patch-clamp
ampliﬁer. The standard pipette (internal) solution contained (in
mM): 101 CsCl, 2 MgCl
 
2
 
, 20 TEACl, 10 MgATP, 8 Tris, 10 EGTA,
and 5.8 glucose (pH 7.4 with CsOH). The standard bath (exter-
nal) solution contained (in mM): 114 NaCl, 2 MgCl
 
2
 
, 1 CaCl
 
2
 
, 5
KCl, 5 Hepes, 5 glucose, and 70 sucrose (pH 7.4 with NaOH). In
those experiments studying external isethionate block, the bath
solution with isethionate contained (in mM): 76 isethionate, 75
NaCl, 5 KCl, 5 glucose, 5 Hepes, 2 MgCl
 
2
 
, and 1 CaCl
 
2
 
. The con-
trol bath solution contained (in mM): 152 sucrose, 75 NaCl, 5
KCl, 5 glucose, 5 Hepes, 2 MgCl
 
2
 
, and 1 CaCl
 
2
 
. 10 
 
 
 
M forskolin
was used to activate the channel activity. Pulse and PulseFit pro-
gram (Heka Electronic) was used to generate the voltage step
protocol and collect the data. Cells were held at 0 mV before the
voltage was stepped to various potentials from 
 
 
 
120 to 120 mV
for 500 ms in 20-mV increments, and then back to 0 mV. Current
responses were ﬁltered at 5 kHz and digitized online at 10 kHz.
Steady-state currents were measured as the average current value
of ﬁnal 50 ms of the voltage step.
 
Data Analysis
 
For quantitative analysis of glibenclamide blockade, channel
open probability (Po) was estimated from all-point amplitude
histograms using the PAT program (Version 7.0, Strathclyde
Electrophysiology Software). Single-channel kinetic analysis was
performed using the software written by Dr. Csanády (Csanády,
2000). This program allows extraction of individual rate con-
stants, given a kinetic model. All curve ﬁttings were performed
with Igor Pro program (Version 3.11, Wavemetrics) using a
Levenberg-Marquardt algorithm. For quantitative analysis of
isethionate blockade, net K1250A-CFTR single-channel I-V rela-
tionships were obtained by subtracting the I-V relationship of
the leak (i.e., basal conductance before the channel is opened)
from that of a single locked-open K1250A-CFTR channel. Usu-
ally, several voltage ramps were applied during a single opening
to generate the I-V relationships. The average of these I-V rela-
tionships were then calculated to represent the single-channel
I-V curve of K1250A-CFTR. Because of the small conductance of
the CFTR channel and the extra noise introduced by the
blocker, the signal-to-noise ratio is often jeopardized even when
the current is ﬁltered at 100 Hz. Therefore, we ﬁt the averaged
single-channel I-V curve with a four term polynomial function
(ﬁtted I-V). Fraction of block (Fb) was calculated according to
the equation:
where I
 
b
 
 and I
 
o
 
 represent the ﬁtted values of the block and un-
blocked current, respectively. Since Fb of isethionate was ob-
tained in an open channel without interference of fast ﬂickery
block, a simple two state scheme (i.e., open 
 
↔
 
 blocked) was used
for data analysis. Dissociation constant (
 
K
 
d
 
) for isethionate block
can then be calculated according to Gupta and Linsdell (2002):
 
(1)
 
To calculate 
 
K
 
d
 
 for glibenclamide block from single-channel
data, a three state kinetic scheme (i.e., blocked 
 
↔
 
 open 
 
↔
 
blocked) was used since the presence of fast ﬂickery block in sin-
gle-channel recordings has to be taken into account (see 
 
re-
sults
 
 for details). The relationship between 
 
K
 
d
 
 and Fb was de-
scribed by Sheppard and Robinson (1997) as:
Fb 1 Ib ()Io () , ⁄ – =
Kd 1F b – () Isethionate [] Fb ⁄ . =
 
(2)
 
where P
 
oc
 
 represents the open probability in the absence of the
blocker.
Voltage dependence of the on rate (k
 
on
 
[V]) and off rate
(k
 
off
 
[V]) of the blocker was estimated using Eqs. 3 and 4 accord-
ing to the rate theory:
 
(3)
(4)
 
where k
 
on
 
(V)
 
 
 
 is the second-order rate constant for blocker bind-
ing, k
 
on
 
(0)
 
 
 
 is the second-order rate constant for blocker binding
at 0 mV, k
 
off
 
(0) is the off rate of the blocker at 0 mV, [X] is the
concentration of the blocker, 
 
 
 
on
 
 is the electrical distance of the
entry barrier, 
 
 
 
off
 
 is the electrical distance of the exit barrier (
 
 
 
on
 
and 
 
 
 
off
 
 have values between 0 and 1), z is the valence of the
blocker (a value of 
 
 
 
1 is assumed for glibenclamide and
isethionate), and F, R, and T have their usual thermodynamic
meanings. Voltage dependence of 
 
K
 
d
 
 (
 
K
 
d
 
[V]) was estimated ac-
cording to the following equation:
 
(5)
 
where 
 
K
 
d
 
(0) is the dissociation constant of the blocker at 0 mV;
 
 
 
K
 
d
 
 is the sum of 
 
 
 
on
 
 and 
 
 
 
off
 
 and represents the electrical distance
of the blocker binding site from the inside of the channel.
All averaged data are expressed as means 
 
 
 
 SEM; 
 
n
 
 represents
the number of patches. Student 
 
t
 
 tests were performed using Sig-
maPlot (version 4.0) and effects were considered signiﬁcant if
P 
 
 
 
 0.05.
 
RESULTS
 
Glibenclamide Block of K1250A-CFTR Channels
 
Previous studies show that glibenclamide blocks CFTR
channels with a time constant in the range of tens of
milliseconds that is slow enough to be resolved in sin-
gle-channel recordings (Schultz et al., 1996; Sheppard
and Robinson, 1997). However, this time constant of
glibenclamide block is very close to the closed time
constant of ATP-gated events in wt-CFTR (Zeltwanger
et al., 1999). Thus, unless ATP-dependent gating is de-
liberately retarded, it is very difﬁcult to dissect these
two events kinetically. That glibenclamide may affect
CFTR gating (Zeltwanger et al., 2000) further compli-
cates the analysis and interpretation. To extract the ki-
netic parameters of glibenclamide-induced blocking
events with minimal contamination of ATP-dependent
gating events, we studied glibenclamide block with a
CFTR mutant, K1250A-CFTR, instead of wt-CFTR. The
advantage of using K1250A-CFTR is that this channel,
once opened by ATP, can stay open for minutes even af-
ter a complete removal of ATP. By collecting data
within a prolonged channel opening, we can study pri-
marily glibenclamide-induced blocking events.
Kd 1F b – () Poc Glibenclamide [] Fb, ⁄ =
kon V () kon V () ′ X [] kon 0 () ′X [] zδonFV RT ⁄ () exp ==
koff V () koff V () z – δoffFV RT ⁄ () , exp =
Kd V () koff V ()kon V () ′ ⁄
koff 0 ()kon 0 () ′ ⁄ z – δon δoff + [] FV RT ⁄ () exp
Kd 0 () z – δKdFV RT ⁄ () , exp
=
=
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We ﬁrst tested whether glibenclamide block of
K1250A-CFTR channels is similar to that of wt-CFTR
channels. Fig. 1 A shows an example of glibenclamide-
induced block recorded from an inside-out patch ex-
cised from an NIH3T3 cell stably expressing K1250A-
CFTR. K1250A-CFTR currents were ﬁrst activated by
PKA and 1mM ATP (not depicted). In this particular
example, at least three channels were activated and
locked open. PKA and ATP were then removed and
currents were allowed to relax. When there was only
one channel left open, 50  M glibenclamide was added
to the superfusion solution. Glibenclamide-induced
block was observed within seconds of the solution
change (presumably limited by the speed of solution
exchange). The block was readily reversed once the
blocker was removed. Fig. 1 B shows expanded single-
channel current traces before, during, and after glib-
enclamide application. Before application of glibencla-
mide, the channel stays in the locked-open state with
occasional brief closings (i.e., ﬂickery blocked state; see
Zhou et al., 2001b). Glibenclamide (50  M) induces
frequent closed events that last for tens of milliseconds.
In this particular experiment, open probability (Po)
was reduced from 0.96 to 0.50 in the presence of 50  M
glibenclamide, and returned to 0.94 after glibencla-
mide was removed. There is no signiﬁcant difference
between the Po values before and after glibenclamide
application (Fig. 1 C) (P   1.0). Therefore, glibencla-
mide-induced block in K1250A-CFTR channels is com-
pletely reversible as seen in wt-CFTR (Schultz et al.,
1996; Sheppard and Robinson, 1997; Gupta and Lins-
dell, 2002; cf. Sheppard and Welsh, 1992).
Next, we examined the sensitivity of K1250A-CFTR to
glibenclamide block. Fig. 2 A shows representative sin-
gle-channel current traces in the presence of various
amounts of glibenclamide. As [glibenclamide] is in-
creased, more blocked events are observed. Po be-
fore  and during glibenclamide application was ob-
tained from all-point amplitude histograms. Fraction
of block (Fb) was calculated as 1   Pow/ glibenclamide/
Pow/o glibenclamide (Fig. 2 B). The resulting dose–response
relationship can be ﬁtted with a Michaelis-Menten
function with a K1/2 of 49.4   9.5  M at  50 mV, which
is similar to that reported for wt-CFTR (Schultz et al.,
1996; Sheppard and Robinson, 1997), indicating that
the K1250A mutation does not affect the sensitivity of
the channel to glibenclamide.
We then tested whether glibenclamide blocks K1250A-
CFTR channels in a voltage-dependent manner as
shown for wt-CFTR channels (Sheppard and Robin-
son, 1997; Gupta and Linsdell, 2002). Fig. 3 A shows
single-channel current traces at various membrane
potentials in the presence of 50  M glibenclamide. Po
at each voltage was used to calculate Fb as described
above. Fb increases with hyperpolarization as seen in
wt-CFTR (Fig. 3 B, top). Using Eq. 2, we calculated
Kd values at various voltages and the resulting data
were ﬁtted with Eq. 5 (Fig. 3 B, bottom), which yields
a  Kd of 0.45   0.03. This voltage dependence is simi-
lar to those reported previously for wt-CFTR (Shep-
pard and Robinson, 1997; Gupta and Linsdell,
2002). We therefore conclude that the mechanisms
of voltage dependence of glibenclamide block for
K1250A-CFTR channels can also be applied to wt-
CFTR channels.
Figure 1. Glibenclamide block of K1250A-CFTR is reversible.
K1250A-CFTR channel currents were activated by PKA and 1 mM
ATP in an excised inside-out patch held at  50 mV with symmetric
Cl  (154 mM [Cl ]o/154 mM [Cl ]i). (A) Continuous recording
of K1250A-CFTR after the channels were locked open with PKA
and ATP. 50  M glibenclamide, applied to the internal solution,
exhibited its blocking effect within seconds. After washout of glib-
enclamide, single-channel current was reversed. (B) Expanded
single-channel current traces before (Control), during and after
(Washout) application of 50  M glibenclamide. (C) Average Po
from four patches before (Control), during (Glib), and after
(Washout) the application of 50  M glibenclamide. Dashed lines
indicate the baseline level. Downward deﬂections represent chan-
nel openings.651 Zhou et al.
Whole-cell Recordings of Glibenclamide Block 
of K1250A-CFTR
With single-channel recordings in excised inside-out
patches, we were only able to investigate glibenclamide
block at negative membrane potentials since patches
became unstable when held at positive potentials for
a long period of time (essential for kinetic analysis).
To observe glibenclamide’s blocking behavior over a
broad voltage range, we switched to whole-cell patch-
clamp recordings. After establishment of a whole-cell
Figure 2. Dose–response relationship of glibenclamide block. (A) Single-channel current traces in the presence of various concentra-
tions of glibenclamide. Inside-out patches were held at  50 mV under symmetric Cl  condition (154 mM [Cl ]o/154 mM [Cl ]i). (B)
Dose–response relationship of glibenclamide block. Each point represents the average from three to nine patches. Data are ﬁtted with the
Michaelis-Menten function (solid line): Fb   Fbmax[X]/(K1/2   [X]), where Fbmax is the maximal fraction of block, [X] is the blocker con-
centration and K1/2 is the concentration of blocker at which the fraction of block is half of the maximum.
Figure 3. Voltage dependence of glibenclamide block. (A) Single-channel current traces in the presence of 50  M glibenclamide at var-
ious membrane potentials. (B) Relationship between fraction of block (Fb), dissociation constant (Kd) and membrane potential. Fb was
calculated from Po. Kd was calculated according to Eq. 2. Solid line denotes a ﬁt of Eq. 5 to the results ( Kd   0.45   0.03). Each point rep-
resents the average from 3 to 13 patches.652 Glibenclamide and Isethionate Blockade of CFTR
conﬁguration, 10  M forskolin was applied to the bath
solution to activate the channels. When whole-cell mac-
roscopic currents reached a steady-state level, glibencla-
mide was added to the superfusion solution. It usually
took several minutes for glibenclamide block to reach
its steady-state. Fitting the time course of current inhi-
bition with a single exponential function gave an aver-
age time constant of 76   13 s (n   3). This prolonged
time course of glibenclamide block in the whole-cell
conﬁguration, contrary to the much faster block in in-
side-out patches (Fig. 1 A), is likely due to a slow per-
meation of glibenclamide through the cell membrane.
Glibenclamide, although applied to the extracellular
side of the channel, exerts its blocking effect from the
intracellular side of the channel as proposed by others
(Schultz et al., 1996; Sheppard and Robinson, 1997;
Gupta and Linsdell, 2002). Supporting this notion,
the dose–response relationship of glibenclamide block
measured from whole-cell experiments yielded a simi-
lar K1/2 as that from single-channel experiments in in-
side-out patches (unpublished data).
To study the voltage dependence of glibenclamide
block in whole-cell conﬁguration, we held the mem-
brane potential at 0 mV and then stepped it to various
voltages from  120 to 120 mV for 500 ms in 20-mV in-
crements. Before the application of forskolin (Fig. 4 A,
control), whole-cell basal (leak) conductance is mini-
mal (whole-cell resistance   3.9 G  for this particular
cell), indicating very little basal CFTR channel activ-
ity. Once the forskolin-activated current reached a
steady-state level, voltage steps were applied again. Net
K1250A-CFTR current traces were obtained by subtract-
ing the leak from the forskolin-activated current (Fig. 4
A). Note that the whole-cell current traces are mostly
time independent except at very high negative mem-
brane potentials where fast current relaxations are ob-
served. These time-dependent currents at negative
membrane potentials are caused by an intrinsic voltage-
dependent ﬂickery block that has been characterized
previously (Zhou et al., 2001b; see below). In the pres-
ence of 50  M glibenclamide, in addition to the fast re-
laxation component, a much slower current relaxation
is observed together with a decrease of the steady-state
current at hyperpolarizing voltages (Fig. 4, A and B).
Net steady-state I-V relationships in the presence or ab-
sence of glibenclamide are shown in Fig. 4 C. Clearly,
glibenclamide blocks whole-cell K1250A-CFTR currents
in a voltage-dependent manner with more block at neg-
ative voltages. Fb was calculated from the steady-state
currents and summarized results are shown in Fig. 4 D.
The values of Fb obtained from single-channel record-
ings (from Fig. 3 B) are superimposed. The agreement
between these two sets of data not only supports the no-
tion that glibenclamide, even applied extracellularly,
blocks CFTR channels from the cytoplasmic side, but
also suggests that the voltage dependence of glibencla-
Figure 4. Glibenclamide
block of whole-cell K1250A-
CFTR currents. (A) Whole-
cell currents in response to
voltage steps from  120 to
120 mV for 500 ms in 20-mV
increments under symmetric
Cl  condition (125 mM
[Cl ]o/125 mM [Cl ]i). 10
 M forskolin (Fsk) or 10  M
Fsk/50   M glibenclamide
(Glib) was applied to the su-
perfusion (external) solution.
Net currents in the presence
of 10  M Fsk (b-a) or 10  M
Fsk/50   M Glib (c-a) were
obtained by subtracting the
leak current (Control, a)
from the current responses in
the presence of 10  M Fsk
(b) or 10  M Fsk/50  M Glib
(c). (B) Steady-state current-
voltage (I-V) relationships of
the leak ( ), 10  M Fsk ( ),
and 10  M Fsk/50  M Glib
( ). (C) Net I-V relationships
in the presence of 10  M Fsk
( ) and 10  M Fsk/50  M
Glib ( ). (D) Voltage dependence of glibenclamide block of K1250A-CFTR. Fraction of block in the presence of 50  M glibenclamide
( ) in whole-cell recordings was calculated from steady-state macroscopic currents. Fraction of block obtained from single-channel re-
cordings ( ; from Fig. 3 B) are superimposed.653 Zhou et al.
mide block measured over a limited voltage range in
excised patches can be applied to a broader voltage
range.
Kinetic Analysis of Voltage-dependent Block of Glibenclamide 
on K1250A-CFTR
For glibenclamide block of K1250A-CFTR, we were
able to apply a simple scheme for kinetic analysis
(Scheme I).
where O, GB, and FB represent the open state, glib-
enclamide-blocked state, and the intrinsic ﬂickery
block state, respectively. kon is the apparent on rate of
glibenclamide, which is the product of the second-
order rate constant for glibenclamide binding (kon )
and [glibenclamide], and koff is the off rate of glib-
enclamide. The parameters kf and k f are the apparent
on and off rate of the blockade by the intrinsic blocker,
respectively. According to this scheme, the open time
distribution will follow a single exponential function
and the mean open time should be equal to 1/(kon   kf),
whereas the closed time distribution will follow a
double exponential function with one component (i.e.,
1/koff) representing the glibenclamide-induced blocked
events and the other (1/k f) representing the closed
events induced by intrinsic ﬂickery blockings. Previous
studies suggest that the mean blocked time of glib-
enclamide is about an order of magnitude longer than
that of the intrinsic blocker (Schultz et al., 1996; Shep-
pard and Robinson, 1997; Zhou et al., 2001b), there-
fore, we should be able to separate these two compo-
nents readily.
Using the PAT analysis program, we constructed
dwell-time histograms from the single-channel record-
ings in the presence of 12.5 or 50  M glibenclamide
(Fig. 5 A). As predicted, the open time histograms can
be well ﬁtted with a single exponential function (Fig. 5
A, solid curves) and the mean open time decreases with
an increase of [glibenclamide]. Also consistent with
Scheme I, the closed time histograms can be ﬁtted
with a double exponential function (Fig. 5 A, solid curves)
with both time constants independent of [glibencla-
mide]. Furthermore, as predicted from Scheme I, the
fraction of the second component increases as [glib-
enclamide] is increased. These observations justify the
application of Scheme I in the data analysis. Individual
rate constants for glibenclamide block were extracted
with the software developed by Dr. Csanády (Csanády,
2000). Fig. 5 B shows the resulting on and off rates of
glibenclamide block at various blocker concentrations.
Consistent with the idea of a simple bimolecular reac-
tion between glibenclamide and the channel (Scheme
SCHEME I
I), the on rate (kon) increases linearly with [glibencla-
mide], whereas the off rate (koff) is little affected by
[glibenclamide]. The lines representing the on and off
rates intersect at 49.1  M (i.e., Kd), which is nearly
identical to the K1/2, estimated from the dose–response
relationship described above (Fig. 2 B). The agreement
between this Kd value, obtained from kinetic parame-
ters based on Scheme I, and the model-independent
K1/2 further demonstrates that Scheme I is adequate for
describing glibenclamide block of K1250A-CFTR chan-
nels.
We then used the same method to obtain kinetic pa-
rameters for glibenclamide block at various membrane
potentials. Visual inspections of the current traces
shown in Fig. 3 A suggest that both open and blocked
Figure 5. Relationships between kinetic parameters of glibencla-
mide block and glibenclamide concentration. (A) Open time
(left) and closed time (right) histograms in the presence of 12.5
 M (top) or 50  M glibenclamide (bottom). Open time histo-
grams are ﬁtted with a single exponential function (solid curve).
Closed time histograms are ﬁtted with a double exponential func-
tion (solid curve). The percentages of the slower component are
21% and 49% in the presence of 12.5 and 50  M glibenclamide,
respectively. (B) Relationships between the on ( ) and off ( )
rates of glibenclamide and glibenclamide concentrations. Solid
line is a linear ﬁt to the on rates. Dashed line is drawn by eyes to ﬁt
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durations change with voltages. Membrane hyperpolar-
ization increases both the number and duration of
blocked events. Results from kinetic analysis indeed
show that both kon and koff are voltage dependent (Fig.
6, ﬁlled symbols). Fitting the data in Fig. 6 with Eqs. 3
and 4 yields the values for  on of 0.16   0.02 and  off of
0.28   0.03 from inside of the channel. Thus, dissocia-
tion of glibenclamide seems somewhat more voltage
dependent than association.
It has been shown that changing external [Cl ] af-
fects the voltage dependence of blockers applied from
inside (Linsdell and Hanrahan, 1996b; Linsdell et al.,
1997; Sheppard and Robinson, 1997; Zhou et al.,
2001b). We therefore examined the effect of extracel-
lular [Cl ] on glibenclamide block. Fig. 7 A shows sin-
gle-channel current traces in the presence of 50  M
glibenclamide with external Cl  removed. Compared
with glibenclamide block with 154 mM external Cl 
(Fig. 3 A), at any given membrane potential, channels
stay in the open state shorter but in the blocked state
longer. Thus, the Fb values in the absence of external
Cl  are higher than those in the presence of external
Cl  at all tested voltages (i.e., lower Kd at each voltage,
Fig. 7 B). In addition, the slope of the voltage depen-
dence curve is less steep (estimated  Kd   0.32   0.05)
in the absence of external Cl  than that in the presence
of 154 mM external Cl  (Fig. 7 B). Results from single-
channel kinetic analysis indicate that both the on and
off rates of glibenclamide block are sensitive to the
presence of extracellular Cl  (Fig. 6). In the absence of
extracellular Cl , the on rates are larger at all voltages
tested compared with those in the presence of 154 mM
external Cl , whereas the off rates become smaller.
Nevertheless, both the on and off rates are still voltage
dependent (Fig. 6, open symbols). From the voltage de-
pendence of kon and koff, the estimated electrical dis-
tances of glibenclamide measured from inside of the
Figure 6. Voltage dependence of the on and off rates of glib-
enclamide block. Rates are extracted according to Scheme I. The
on ( ) and off rates ( ) under symmetric Cl  condition (154 mM
[Cl ]o/154 mM [Cl ]i), and the on ( ) and off rates ( ) in the
absence of external Cl  (0 [Cl ]o/154 mM [Cl ]i) are plotted
against the membrane potential. Solid lines are single exponential
ﬁts to the data. The differences between paired values (154 mM
[Cl ]o versus 0 [Cl ]o) at all voltages are statistically signiﬁcant
(P   0.05) except the on rates at  110 mV (P   0.08).
Figure 7. Voltage dependence of glibenclamide block in the absence of external Cl . (A) Single-channel current traces at various mem-
brane potentials in the presence of 50  M glibenclamide. (B) Voltage dependence of Kd in the absence of external Cl  ( ) and in the
presence of 154 mM [Cl ]o ( ). The differences between paired values at all voltages are statistically signiﬁcant (P   0.05) except at  110
mV (P   0.06). Data are ﬁtted with Eq. 5 (solid lines).  Kd   0.45   0.03 in the presence of 154 mM [Cl ]o.  Kd   0.32   0.05 in the ab-
sence of external Cl .655 Zhou et al.
pore in the absence of external Cl  are 0.14   0.01
( on) and 0.19   0.04 ( off), respectively.
Voltage-dependent Block of K1250A-CFTR Channels
by Isethionate
Glibenclamide is a powerful tool to probe the CFTR
pore because it affords direct measurements of both
the on and off rate constants. However, this advantage
is counteracted by the fact that a considerable single-
channel signal-to-noise ratio is required for kinetic
analysis. In addition, a fairly long duration of single-
channel recording is necessary for collecting sufﬁcient
events. This latter requirement is especially problem-
atic because membrane patches are unstable at rela-
tively positive membrane potentials, precluding de-
tailed quantiﬁcation of glibenclamide block at positive
voltages. We therefore set out to try several hydrophilic
fast blockers to probe the CFTR pore.
We screened three large hydrophilic anions: gluco-
nate, glutamate, and isethionate. Gluconate and glu-
tamate are known CFTR channel blockers (Linsdell
and Hanrahan, 1996b; Linsdell et al., 1997) and they
block CFTR channels from intracellular side of the
pore with a fast time scale. On the other hand, isethio-
nate is used commonly as a replacement for Cl  and
there is no report so far that isethionate blocks CFTR
channels. To our surprise, isethionate decreases the
single-channel amplitude as if it also blocks the CFTR
pore with a fast time scale (see below). To compare
their ability to block K1250A-CFTR channels, we ap-
plied voltage ramps on inside-out patches in the pres-
ence or absence of various blockers in the perfusion so-
lution. Fig. 8 A shows representative I-V curves of con-
trol and those in the presence of various blockers. All
three anions block K1250A-CFTR channels in a voltage-
dependent manner. However, at the same concentra-
tion (100 mM), isethionate shows the strongest block
among these three anions. For example, at  100 mV,
the values of Fb are 0.67   0.01 (n   7), 0.46   0.02
(n   7), and 0.33   0.06 (n   3) for isethionate, glu-
conate, and glutamate, respectively. Therefore, we fo-
cused on isethionate for the rest of the study. Fig. 8 B
demonstrates that the voltage dependence of glibencla-
mide and isethionate block are very similar despite the
very different time scales of action. Indeed, when the
voltage-dependent Kd is quantiﬁed with Eq. 5, the elec-
trical distance,  Kd, of isethionate block (0.45   0.03) is
identical to that of glibenclamide.
Fig. 9 A shows single-channel I-V curves in the pres-
ence of various concentrations of isethionate. The
higher the concentration of isethionate, the smaller the
single-channel amplitude. The values of Fb in the pres-
ence of different concentrations of isethionate were cal-
culated as described above. The dose–response relation-
ship, when ﬁtted with the Michaelis-Menten function,
yields a K1/2 of 89.6   3.4 mM at  50 mV (Fig. 9 B).
To test whether isethionate can also block the chan-
nel from the extracellular side, we applied isethionate
Figure 8. Voltage-dependent block of K1250A-CFTR by hydrophilic organic an-
ions. (A) Single-channel current-voltage (I-V) relationships under symmetric Cl 
condition (154 mM [Cl ]o/154 mM [Cl ]i) recorded from the same patch in the
presence or absence of various blockers. Blockers were applied to the superfusion
(internal) solution. From bottom to top: control, 100 mM glutamate, 100 mM glu-
conate, and 100 mM isethionate. Solid curves are polynomial ﬁts to the data. (B)
Voltage dependence of the fraction of block (Fb) in the presence of 100 mM
isethionate in the internal solution ( ). Fb in the presence of 50  M glibencla-
mide was taken from Fig. 3 B for comparison ( ). (C) Voltage dependence of Kd
in the presence of 100 mM isethionate ( ) and 50  M glibenclamide ( ; taken
from Fig. 3 B). Kd values for isethionate were calculated from Fb values shown in
(B) according to Eq. 1.656 Glibenclamide and Isethionate Blockade of CFTR
to the external solution in whole-cell recordings. Volt-
age-step protocols similar to those described above
were performed (see Fig. 4) and representative current
traces are shown in Fig. 10 A. In the presence of 76 mM
isethionate in the external solution, the net whole-cell
currents are similar to those of control. The steady-state
I-V relationships in the absence or presence of external
isethionate are nearly identical (Fig. 10 B), indicating
that isethionate, at the tested concentration, has a neg-
ligible effect on CFTR current when applied from the
external side of the channel.
Effect of Extracellular and Intracellular Cl  on Isethionate Block
To investigate whether intracellular Cl  affects isethio-
nate block, we increased [Cl ] in the bath solution to 300
mM (since it is technically difﬁcult to maintain the ex-
cised patch at lower intracellular [Cl ]) and tested
isethionate block using the same ramp protocol de-
scribed above. In the presence of 300 mM intracellular
Cl , Kd values become larger compared with those in the
presence of 154 mM intracellular Cl  at all voltages tested
(Fig. 11 A).  Kd, estimated from the voltage dependence
of Kd in the presence of 300 mM intracellular Cl , is
Figure 9. Dose–response relationship of internal isethionate block. (A) Single-channel current-voltage (I-V) relationships in the pres-
ence or absence of various amounts of isethionate under symmetric Cl  condition (154 mM [Cl ]o/154 mM [Cl ]i). Isethionate was ap-
plied to the superfusion (internal) solution. From bottom to top: control, 20 mM isethionate, 50 mM isethionate, 100 mM isethionate and
200 mM isethionate. Solid lines are polynomial ﬁts to the data. (B) Dose–response relationship of internal isethionate block. Fraction of
block at  50 mV was obtained from I-V relationship. Solid line is the Michaelis-Menten ﬁt to the data with a K1/2 of 89.6   3.4 mM (see
Fig. 2 legend).
Figure 10. Effect of ex-
tracellular isethionate on
K1250A-CFTR whole-cell cur-
rent. (A) Whole-cell current
response to voltage steps
from  120 to 120 mV for 500
ms in 20-mV increments in
the absence or presence of
76 mM external isethionate.
K1250A-CFTR currents were
activated by 10  M Fsk. Net
currents were obtained by
subtracting the basal cur-
rents from that in the pres-
ence of 10  M Fsk. (B)
Steady-state current-voltage
relationships in the absence
( ) or presence of 76 mM ex-
ternal isethionate ( ). Cur-
rents at different membrane
potentials are normalized to
that at  100 mV.657 Zhou et al.
0.50   0.01, which is similar to that in the presence of
154 mM intracellular Cl  (Fig. 11 A). This result is consis-
tent with the idea that intracellular Cl  and isethionate
may compete for the same binding site. When the con-
centration of competing Cl  ions is increased, less block
and a larger Kd are expected because of a lower probabil-
ity of occupancy by isethionate at its binding site.
To test whether extracellular Cl , as in the case of
glibenclamide block, affects isethionate block, we re-
placed Cl  completely with aspartate in the pipette so-
lution and examined isethionate block. In the absence
of external Cl , isethionate block still shows voltage de-
pendence and Kd values become smaller compared
with those in the presence of 154 mM external Cl 
(Fig. 11 B).  Kd, estimated from the voltage depen-
dence of Kd, is 0.37   0.01, a value smaller than that in
the presence of 154 mM external Cl  (0.45   0.03),
but similar to the  kd (0.32   0.05) for glibenclamide
block in the absence of external Cl  (Fig. 7 B). This re-
sult further supports the idea that glibenclamide and
isethionate may share a common binding site.
Block of K1250A-CFTR by Mixture of
Glibenclamide and Isethionate
If indeed these two blockers share a common binding
site, then the kinetics of channel blockade by these two
blockers can be described as:
SCHEME II
where X, XG, and XI represent the binding site, glib-
enclamide-occupied state and isethionate-occupied
state, respectively. kon  is the second-order rate constant
for glibenclamide binding and koff is the off rate of glib-
enclamide. k 1 is the off rate of isethionate and k1 is the
second-order rate constant for isethionate binding; [G]
and [I] represent the concentrations of glibenclamide
and isethionate respectively. According to Scheme II,
the fractional block in the presence of both glibencla-
mide and isethionate (FbG I) is given by:
(6)
where Kd(G) and Kd(I) are the dissociation constants of
glibenclamide and isethionate, respectively. Since both
Kd(G) and Kd(I) are known, we can calculate FbG   I at dif-
ferent combinations of glibenclamide and isethionate
and experimentally verify the predictions. Fig. 12 A
shows representative single-channel current traces and
corresponding all-point amplitude histograms at –50
mV. In the presence of 6.25  M glibenclamide plus 20
mM isethionate, both Po and single-channel amplitude
decrease compared with those of control. When the
concentrations of the blockers are increased, Po and
single-channel amplitude further decrease. FbG   I was
calculated as the ratio of the mean current, which takes
into account both Po and the single-channel ampli-
tude, in the presence of blockers and that in the ab-
sence of blockers. In all four different combinations of
these two blockers, the experimentally measured FbG   I
are in good agreement with the theoretical values
FbG 1 +
Kd(l) G [] Kd(G) I [] +
Kd(l) G [] Kd(G) I [] Kd(G)Kd(l) ++
-----------------------------------------------------------------------------, =
Figure 11. Effects of internal and external Cl  concentrations on the voltage dependence of internal isethionate block. (A) Voltage de-
pendence of Kd of isethionate block in the presence of 154 mM [Cl ]i ( ) or 300 mM [Cl ]i ( ). [Cl ]o is 154 mM. The differences be-
tween paired values at all voltages are statistically signiﬁcant (P   0.05). Kd values are ﬁtted with Eq. 5 (solid lines).  Kd   0.45   0.03 in the
presence of 154 mM [Cl ]i.  Kd   0.50   0.01 in the presence of 300 mM [Cl ]i. (B) Voltage dependence of Kd of isethionate block in the
presence of 154 mM [Cl ]o ( ) or 0 mM [Cl ]o ( ). [Cl ]i is 154 mM. The differences between paired values at all voltages are statisti-
cally signiﬁcant (P   0.05). Kd values are ﬁtted with Eq. 5.  Kd   0.37   0.01 in the absence of external Cl .  Kd   0.45   0.03 in the pres-
ence of 154 mM [Cl ]o.658 Glibenclamide and Isethionate Blockade of CFTR
based on Scheme II (Fig. 12 B). Scheme II also predicts
that the apparent on rate of glibenclamide would de-
crease in the presence of isethionate since glibencla-
mide cannot bind when isethionate occupies the bind-
ing site, but the off rate would not be affected by
isethionate. Since isethionate, being a fast blocker, re-
duces the single-channel amplitude and introduces ex-
tra open channel noise, we were only able to reliably
perform our single-channel kinetic analysis at a low
concentration of isethionate. Our results show that in
the presence of 20 mM isethionate, the apparent on
rate of glibenclamide (6.25  M) is 1.38   0.10 s 1 (n  
5), which is signiﬁcantly slower than that in the pres-
ence of 6.25  M glibenclamide alone (1.83   0.06 s 1,
n   4, see Fig. 5 B) (P   0.05). In fact, this value of glib-
enclamide on rate in the presence of 20 mM isethio-
nate is very close to the predicted value, 1.49 s 1, based
on Scheme II. On the other hand, the off rate of glib-
enclamide in the presence of isethionate is 10.97  
0.53 s 1 (n   5), which is not different from that in the
absence of isethionate (11.07   0.86 s 1, n   4, see Fig.
5 B) (P   0.92).
DISCUSSION
The goal of this study is to use the anion blockers, glib-
enclamide and isethionate, to probe the CFTR channel
pore in order to understand the pore structure. We
found that these two blockers, despite of their drastic
differences in potency and blocking kinetics, show very
similar voltage dependence and sensitivity to changes
of external Cl  concentration. Both anions block the
CFTR channel from the cytoplasmic side of the mem-
brane presumably traversing a signiﬁcant distance into
the pore to their binding site.
With the K1250A-CFTR mutant, we were able to
quantify detailed kinetic parameters of glibenclamide
block not provided by previous studies (Schultz et al.,
1996; Sheppard and Robinson, 1997; Gupta and Lins-
dell, 2002). Our results demonstrate that both the on
rate and the off rate of glibenclamide are voltage de-
pendent (Fig. 6). In the presence of 154 mM external
Cl , the electrical distance estimated from the on rate
and the off rate are 0.16 and 0.28, respectively. The
sum of these two values is close to the measured  Kd
( Kd   0.45), as predicted (see materials and meth-
ods). This latter value is similar to those derived from
the voltage-dependent Kd reported previously for wt-
CFTR (    0.48, Sheppard and Robinson, 1997;    
0.41, Gupta and Linsdell, 2002). It should be noted
that voltage-dependent blockade might not solely re-
ﬂect the fact that the binding site of the blocker is in
the electrical ﬁeld. Studies of K  channels demonstrate
that the voltage dependence of a blocker can be af-
fected by the permeant ions entering the pore from the
opposite side of the channel (e.g., Armstrong, 1971;
Yellen, 1984; MacKinnon and Miller, 1988; Spassova
and Lu, 1998). This trans-ion effect has also been
shown in CFTR channels. External Cl  concentration
can affect the voltage-dependent block by glibencla-
mide (Sheppard and Robinson, 1997; Gupta and Lins-
dell, 2002), glutamate, and gluconate (Linsdell and
Hanrahan, 1996b; Linsdell et al., 1997). We have also
Figure 12. Block of K1250A-CFTR current in the presence of both glibenclamide and isethionate. (A) Single-channel current traces
(left) and corresponding all-point amplitude histograms (right) in the absence (control) or presence of blockers, glibenclamide (Glib)
and isethionate (Ise). Vm    50 mV. (B) Fraction of block in the presence of Glib and Ise (FbG   I) with four different combinations of
Glib and Ise. A, C, E, and G (black bars) are the predicted FbG   I values according to Scheme II and Eq. 6. B, D, F, and H (open bars) are
experimental data.659 Zhou et al.
reported that the voltage dependence of the intrinsic
ﬂickery blocking events seen in a locked-open K1250A-
CFTR channel is mostly determined by the trans-ion ef-
fects (Zhou et al., 2001b). We tested the effect of exter-
nal Cl  on kinetic parameters of glibenclamide block.
Our results show that the afﬁnity of glibenclamide, as
judged by Kd values, increases when external Cl  is re-
moved (Fig. 7 B). Detailed kinetic analysis show that
the on rate of glibenclamide becomes faster and the off
rate becomes slower in the absence of external Cl 
(Fig. 6). These observations suggest the presence of a
Cl  binding site external to the site for glibenclamide
in the CFTR pore. Binding of Cl  ions at this external
site destabilizes glibenclamide binding.
It should be noted that Scheme I is the simplest
model that is adequate to explain our results. We can-
not rule out the possibility of other more complicated
schemes. For example, the channel may be occupied by
glibenclamide and the intrinsic blocker simultaneously.
One would then expect three components in the
closed time distribution. That the closed time distribu-
tion can be ﬁtted quite well with a double exponential
function (Fig. 5 A) suggests that if indeed the third
component exists, it is not resolved under our experi-
mental conditions. Unfortunately, the molecular na-
ture of the intrinsic blocker remains a mystery. Future
identiﬁcation of the intrinsic blocker will permit differ-
entiation of different kinetic schemes. Nevertheless,
this limitation applied to glibenclamide blockade is not
a concern for isethionate block because the block is as-
sessed without a contamination of ﬂickery block.
The voltage-dependent block of the CFTR pore is
also seen with isethionate, a hydrophilic organic anion
commonly used as a Cl  substitute. Like other large hy-
drophilic anions, such as gluconate and glutamate
(Linsdell and Hanrahan, 1996b; Linsdell et al., 1997),
isethionate blocks CFTR channels in a voltage-depen-
dent manner with a fast time scale. Surprisingly, ise-
thionate is more potent than the two well-characterized
blockers, gluconate and glutamate (Fig. 8 A). The Kd of
isethionate at  100 mV is 48.7 mM compared with a Kd
( 100 mV) of  80 mM for gluconate (Linsdell and
Hanrahan, 1996b; Linsdell et al., 1997) and a Kd ( 100
mV) of 325 mM for glutamate (Linsdell and Hanrahan,
1996b). Therefore, isethionate can be considered as a
new tool to probe the CFTR pore.
Glibenclamide and isethionate block CFTR channels
with different kinetics, and their binding afﬁnities dif-
fer by three orders of magnitude. However, our results
suggest that these two blockers may share a common
binding site. First, the voltage dependence of glibencla-
mide block and isethionate block are nearly identical
in the presence of 154 mM external Cl  (Fig. 8, B and
C). Second, in the absence of external Cl , the esti-
mated  Kd values for both blockers are again very simi-
lar to each other, indicating that their voltage depen-
dence is equally sensitive to changes of external Cl 
concentration. Third, when glibenclamide and ise-
thionate are applied together (Fig. 12), the resulting
FbG   I are compatible with the predicted values based
on Scheme II that glibenclamide and isethionate com-
pete for a common binding site. Although Scheme II
seems reasonable, we cannot completely rule out the
possibility that glibenclamide and isethionate may actu-
ally bind to two different sites that are very close to
each other in the pore. Thus, both blockers can reside
in the pore simultaneously. However, it seems difﬁcult
to envision that isethionate is able to enter a glibencla-
mide-occupied pore (and vice versa), since both block-
ers are fairly large in size. Furthermore, if indeed both
blockers can bind at the same time while binding of
one blocker does not affect binding of the other, the
predicted FbG   I values will be higher than those pre-
dicted from Scheme II. Our experimental data are con-
sistently closer to the values predicted from Scheme II,
and are always smaller than those based on a model
with two binding sites (unpublished data). Computa-
tional modeling based on the crystal structure, when
available, would be able to differentiate between these
two possibilities. Studies using mutants that affect glib-
enclamide and isethionate may also be useful.
If we accept the concept of one common binding site
for both glibenclamide and isethionate, we are able to
make some speculations about the CFTR pore based
on the structural differences between these two block-
ers. Glibenclamide (C23H27ClN3O5S ) is a large hydro-
phobic anion, whereas isethionate (C2H5O4S ) is a rel-
atively small hydrophilic anion. The physical dimen-
sions of both blockers are estimated using a program
written by Dr. Xiaoqin Zou (University of Missouri).
Brieﬂy, the three-dimensional coordinates are gener-
ated by the CONCORD software (Rusinko et al., 1989)
that determines the minimal and maximal coordinates
that are occupied by a molecule along the x, y, and z
axis, respectively. The molecular dimensions are then
derived from these coordinates. The estimated dimen-
sions of glibenclamide and isethionate are 21.4 Å  
13.6 Å   11.6 Å and 8.1 Å   5.8 Å   6.2 Å, respectively.
The slow on rate of glibenclamide (on the order of 105
s 1M 1) is probably due to its large size. Thus, a special
orientation of glibenclamide may be required for the
blocker to move across the internal entrance of the
pore. The on rate of isethionate is likely to be faster
than that of glibenclamide if we assume size is a main
determinant of the on rate. Even if the on rate of both
blockers are the same, the off rate of glibenclamide is
at least a thousandfold slower than that of isethionate,
since the Kd of glibenclamide is about three orders of
magnitude smaller than that of isethionate. The slower
off rate of glibenclamide suggests that glibenclamide660 Glibenclamide and Isethionate Blockade of CFTR
can bind much more stably to its binding site than
isethionate. Since glibenclamide has three hydropho-
bic rings that are lacking in isethionate, we propose
that there are likely to be some hydrophobic compo-
nents in the pore that stabilize glibenclamide binding.
Larger van der Waal’s interactions between glibencla-
mide and the pore may also attribute to the tight bind-
ing. On the other hand, the negative charge of the
blockers is also important, as indicated by previous re-
search (Sheppard and Robinson, 1997). Therefore,
positive charge as well as hydrophobic components in
the pore are important for a stable binding of the
blocker in the CFTR pore. It should be noted that this
conclusion is valid irrespective of whether glibencla-
mide and isethionate bind to the same site or two
nearby sites. Interestingly, based on studies with alkyl-
TEA derivatives, Choi et al. (1993) made a similar con-
clusion on the pore structure of Shaker potassium chan-
nels. The presence of hydrophobic segment(s) in the
aqueous pore is perhaps important to prevent CFTR
channels from being blocked by hydrophilic anions
(e.g., glutamate) present under physiological condi-
tions in the cell.
In order for a blocker as large as glibenclamide to en-
ter the pore from the cytoplasmic side, the internal en-
try of the pore should be at least  11 Å wide, assuming
the dimension of glibenclamide bound to the channel
is similar to that measured from the crystal structure. In
fact, the portion of the pore between the internal en-
trance and the blocker binding site should be as wide.
Although the estimated electrical distance of glibencla-
mide block is only  30% across the electrical ﬁeld after
eliminating the trans-ion effect, the actual physical dis-
tance glibenclamide travels into the pore is perhaps
much larger because this predicted wide tunnel pre-
sents a low-resistance (i.e., smaller voltage drop) path-
way for Cl  ions as well as for water molecules. A similar
discrepancy between electrical distance and physical
distance has been described for the binding site of qua-
ternary ammonium inhibitors in the pore of K  chan-
nels (Yellen et al., 1991; Zhou et al., 2001a). Therefore,
instead of a wide internal vestibule for those sizable
blockers to lodge (Linsdell and Hanrahan, 1996a; Zelt-
wanger et al., 2000), we propose a wide internal en-
trance followed by an at least equally wide tunnel that
the blocker has to traverse before reaching its binding
site.
On the other hand, the external entrance of the pore
is likely to be narrower since blockers, such as disul-
phonic stilbenes (DNDS and DIDS), glutamate, gluco-
nate, and isethionate can only block CFTR channels
when applied intracellularly but not extracellularly
(Gray et al., 1990; Tabcharani et al., 1990; Gadsby et
al., 1995; Linsdell and Hanrahan, 1996a,b). Some
other blockers, such as diphenylamine-2-carboxylate
(DPC), ﬂufenamic acid (FFA), and glibenclamide, are
effective when applied to either side of the membrane.
However, since these blockers are membrane permeant
and it usually takes several minutes for them to exhibit
a full blocking effect, it is likely that these blockers,
even when applied extracellularly, actually block the
channel from inside (Sheppard and Welsh, 1992; Mc-
Carty et al., 1993; Schultz et al., 1996; Sheppard and
Robinson, 1997). Our results from single-channel re-
cordings and whole-cell recordings indeed support the
idea that glibenclamide, even applied extracellularly,
enters the channel from the intracellular side of the
pore. Only small permeant molecules, such as SCN-
and Au(CN)2
 , have been observed to block the chan-
nel from either side of the membrane (Tabcharani et
al., 1993; Mansoura et al., 1998; Smith et al., 1999;
Gong et al., 2002; Linsdell and Gong, 2002; unpub-
lished data). Together, CFTR channel pore may adopt
an asymmetric structure with a relatively large internal
tunnel and a fairly narrow external entrance. The exist-
ence of a stringent external entrance may provide
some evolutionary advantages since CFTR is normally
present in the apical membranes of intestinal epithe-
lia and thus is exposed to a multitude of potential
blockers.
The presence of a large internal tunnel allows us to
make another structural prediction. Since the diameter
of this internal tunnel has to be at least  11 Å, whereas
previous biophysical studies suggest a narrowest region
(i.e., selectivity ﬁlter) of 6 Å in the CFTR pore (Linsdell
and Hanrahan, 1996a), the selectivity ﬁlter should
be located external to the glibenclamide/isethionate
binding site because our data provide no evidence that
glibenclamide or isethionate can pass through the
channel. With the addition of this implied structural in-
formation, one can speculate that an open CFTR pore
structure may show some resemblance to the recently
resolved open-channel structure of the K  channels
(Jiang et al., 2002).
Several of our results support the notion that CFTR
channel has a pore that can be occupied simulta-
neously by multiple anions. First, effects of both block-
ers are sensitive to changes of external Cl  concentra-
tion. Removing external Cl  enhances both glibencla-
mide and isethionate block (Figs. 7 B and 11 B).
Detailed kinetic analysis shows that the off rate of glib-
enclamide is faster in the presence of external Cl  (Fig.
6). We reason that Cl  ions can enter the pore from the
external side to destabilize glibenclamide binding.
Thus, the pore can be occupied by Cl  and glibencla-
mide simultaneously and there is at least one Cl  bind-
ing site external to the glibenclamide/isethionate bind-
ing site. This is also consistent with the picture de-
scribed above that the selectivity ﬁlter (by deﬁnition a
Cl  binding site) is located external to the blocker661 Zhou et al.
binding site. Second, the binding site for the blockers
likely also binds Cl  ions because increasing internal
Cl  concentration results in less block by isethionate
(Fig. 11 A). Therefore, we conclude that at least two
Cl  binding sites are present in the CFTR pore. If these
two binding sites are physically close to each other, a
potential electrostatic repulsion between the two closely
seated Cl  ions can expedite Cl  exit.
Channel’s blockers have been used successfully to ex-
plore the pore structure of ion channels. While the
crystal structure of CFTR channel is not yet available,
blockers remain as powerful tools to study the CFTR
pore. An important remaining question is where the
gate of the CFTR channel is located along the anion-
conducting pore. The slow kinetics of glibenclamide
binding makes this blocker a good candidate to study
the relationship between gating and blocking to gain
more information about the structure of this intriguing
molecule.
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